The key findings were: Tirzepatide met the primary goal of cardiovascular non-inferiority , confirming it is at least as safe for the heart as dulaglutide It did not quite meet statistical superiority over dulaglutide for MACE, although results trended in favour of tirzepatide Tirzepatide produced significantly greater reductions in HbA1c and body weight than dulaglutide Importantly, because SURPASS-CVOT used an active comparator with established cardiovascular benefit rather than a placebo, demonstrating superiority was inherently more difficult than in earlier placebo-controlled GLP-1 outcome trials
Bu nedenle GLP-1 tedavileri, artk yalnzca kilo verme deil
Another one in five patients on semaglutide (the active ingredient in Wegovy and Zepbound) don't lose significant weight, Dr
When convulsions appeared with paracetamol or insulin, they were completely eliminated or markedly attenuated, much like muscle weakness in cuprizone-rats
Store in the refrigerator (2-8C)
Pros: Built for cash-pay patients Active physician oversight compensates for lack of PCP involvement Personalized dosing protocols Peptide therapy options available Cons: $50/month more than the cheapest option No brand-name prescriptions Smaller operation #4
